NCT03090386 Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients Status COMPLETED Phase N/A
NCT03068520 Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression? Status UNKNOWN Phase NA
NCT03052738 Medical Marijuana in the Pediatric Central Nervous System Tumor Population Status COMPLETED Phase N/A
NCT03033706 Intraoperative Goal Directed Fluid Management in Supratentorial Brain Tumor Craniotomy Status COMPLETED Phase NA
NCT02956291 Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors Status COMPLETED Phase NA
NCT02942264 Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT02909777 Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma Status COMPLETED Phase PHASE1
NCT02878707 The Neuroprotective Effects of Dexmedetomidine During Brain Surgery Status COMPLETED Phase NA
NCT02861898 Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT02851706 Natural History of and Specimen Banking for People With Tumors of the Central Nervous System Status COMPLETED Phase N/A
NCT02851355 Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway Status COMPLETED Phase N/A
NCT02844439 Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT02843477 Evaluation of Corrected Carotid Artery Flow Time as a Predictor of Fluid Responsiveness in Spontaneous Breathing Patients Status COMPLETED Phase N/A
NCT02809651 Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner Status COMPLETED Phase NA
NCT02800486 Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Status RECRUITING Phase PHASE2
NCT02768389 Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT02761096 Effect of Acupuncture on Inflammation and Immune Function After Craniotomy Status COMPLETED Phase NA
NCT02740933 Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors Status UNKNOWN Phase PHASE1